Loading this company
Loading this company
We do not publish a fair value for this company. The grade still applies.
$25.11USD down −$0.18 (−0.69%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-19 15:46 UTC (7 hours ago).
Nothing we can cite explains today’s move for this company.
Our cash-flow model doesn't produce a meaningful value for this business — its projected free cash flow is so far from supporting the current price that the result is effectively zero, which tells you about the limits of the model on a fast-growing or loss-making company, not about what the business is worth. Here is what we can show instead.
Our forward range over 12 months is part of Pro. See plans
Analysts’ mean target
$27.92 across 12 analysts
The high and low of the analyst range is part of Pro. See plans
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It operates in the Medical Instruments & Supplies industry (Healthcare sector), headquartered in United States. The company employs roughly 37,500 people.
Prices are delayed. The feed does not say when these figures were taken.
No recent headlines we can cite for this company.
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.
The score, the fair value and the reverse DCF are free on every company. Pro lets you change growth, margin and the discount rate yourself, see every valuation lens and its working, and download the model. Start a 7-day free trial — a card is required and you can cancel any time before it ends. $99 a year, or $14.99 monthly.